NCT07101965View on ClinicalTrials.gov

Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets in Healthy Subjects After Single and Multiple Oral Administration and the Effect of Food on the Pharmacokinetics of RSS0343

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 7, 2024

Primary Completion Date

November 6, 2024

Study Completion Date

November 6, 2024

Conditions

Health Volunteer

Interventions

DRUG

RSS0343 tablets ；placebo

RSS0343 tablets and placebo were given orally as a single dose

DRUG

RSS0343 tablets ；placebo

RSS0343 tablets and placebo were taken orally multiple times

Trial Locations (1)

250013

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital), Shandong

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT07101965 - Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets in Healthy Subjects After Single and Multiple Oral Administration and the Effect of Food on the Pharmacokinetics of RSS0343 | Biotech Hunter | Biotech Hunter